Pebble Life Science is optimizing CB1 and CB2 receptor formulations for chemo-resistant patients to enhance standard of care (PARP inhibitors Cisplatinum) tumor killing, while also providing additional palliative effects during and after chemotherapy treatment...
We focus on the long term by limiting waste upfront and continually seek ways to improve and/or scale...
We are product-driven, meaningfully differentiated and create value thru focus on the patient's best interests.